Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXI No. 8 - June 9, 2014

Bridging the Schism within your Laboratory

THERE’S A SIGNIFICANT SCHISM BECOMING VISIBLE within the house of laboratory medicine. I am calling your attention to this development because this schism probably exists within your own laboratory organization. On one side are a very large number of pathologists, lab administrators, and laboratory scientists who have yet to acknowledge that the lab testing marketplace …

Bridging the Schism within your Laboratory Read More »

To access this post, you must purchase The Dark Report.

Could Health Insurers Be at War with Clinical Labs?

CEO SUMMARY: It may sound ridiculous to assert that the nation’s largest health insurers are now “waging war” against clinical labs. However, some very smart people in the profession of laboratory medicine are expressing this opinion. To support such a conclusion, they point to payers’ recent drastic price cuts and network contracting strategies. Moreover, these …

Could Health Insurers Be at War with Clinical Labs? Read More »

To access this post, you must purchase The Dark Report.

BRLI-Horizon BCBS Lawsuit Is Window to Payer Actions

CEO SUMMARY: Do “actions speak louder than words?” In New Jersey, one lab company sued a major health insurer for “breach of contract and fraud.” Court documents include claims describing how one health insurer became ever more sophisticated in how it played one public lab company against another in order to drive down its lab …

BRLI-Horizon BCBS Lawsuit Is Window to Payer Actions Read More »

To access this post, you must purchase The Dark Report.

PAMA’s New Rules Affect Lab Test Pricing, Coverage

CEO SUMMARY: For several reasons, the “Protecting Access to Medicare Act” (PAMA) has the potential to be the most disruptive federal legislation directed at the clinical lab industry since the enactment of CLIA 1988. Following passage of the law, some lab industry groups have taken different stances toward the positive and negative elements of PAMA. …

PAMA’s New Rules Affect Lab Test Pricing, Coverage Read More »

To access this post, you must purchase The Dark Report.

Calloway Labs Settles with Feds, West Virginia

CEO SUMMARY: West Virginia is the second state in recent years to settle claims of Medicare and Medicaid fraud filed against Calloway Laboratories of Woburn, Massachusetts. Last month, the pain management lab company agreed to pay $4.675 million to resolve that case, while not admitting liability. During the period that Calloway was alleged to have …

Calloway Labs Settles with Feds, West Virginia Read More »

To access this post, you must purchase The Dark Report.

‘Game Changer’ Mass Spectrometry for Microbiology at UNC

CEO SUMMARY: Microbiologists at the University of North Carolina are using MALDI-TOF mass spectrometry to slash the time to answer and significantly cut lab costs. Their goals are to improve patient outcomes and reduce average length of stay. In a one-year study presented last month, UNC microbiologists reported that consumable costs for many microbiology tests …

‘Game Changer’ Mass Spectrometry for Microbiology at UNC Read More »

To access this post, you must purchase The Dark Report.

June 09, 2014 Intelligence: Late-Breaking Lab News”

Inpatient utilization has declined in Boston, Indianapolis, and Newark. That’s the finding of a new report issued May 27 by Kaufman Hall, a consulting firm based in Skokie, Illinois. The data was collected by Tufts Medical Center in Boston; Barnabas Health in West Orange, New Jersey; and Community Health Network in Indianapolis. For the 2010-2012 …

June 09, 2014 Intelligence: Late-Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;